

The question is whether “2026年汉坦病毒疫苗??” occurs by the stated deadline and under the published conditions.
A Yes outcome requires the stated conditions to be met; No covers the alternative.
The qualifying event, evidence source, cutoff time, and any exceptions are documented in the Resolution Rules below.
Waiting for trades
Last 30 days
$5.25K
30-day total
$175.07
Daily average
Every trader on this market, last 7 days
—
24h volume, market-wide
Market-wide, by position value
5 25, 2026 · 19:43 GMT+3
1 1, 2027 · 07:59 GMT+3
1 1, 2027 · 08:29 GMT+3
如果在市场创建至2026年12月31日美国东部时间晚上11:59之间,有任何针对人类并用于预防汉坦病毒(包括汉坦病毒肺综合征(HPS)或出血性肾综合征(HFRS))的疫苗获得美国食品药品监督管理局的全面批准,则本市场将以“是”结算。否则,本市场将以“否”结算。
本市场的主要结算来源将是FDA的官方信息,包括其批准疫苗列表(https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states),但也可能使用可信报道的共识。